How Epigenetics Shapes Brain Diseases

Same Mechanisms, Different Outcomes

Abstract

This report investigates the role of epigenetic mechanisms, like DNA methylation, histone methylation/acetylation, non-coding RNA changes, and microglial priming, in the pathogenesis of neurodegenerative diseases.⁷ This report synthesizes findings from multiple primary research articles to analyze how these mechanisms influence gene expression across different diseases. Consistent patterns of hypermethylation were observed to silence genes critical for mitochondrial function, synaptic integrity, and neuroprotection. Histone modifications further contributed to inflammation and transcriptional dysregulation.² Notably, one counter-study revealed that hypomethylation and gene overexpression of synaptic transport genes in PD led to excitotoxicity, suggesting that epigenetic changes are not uniformly detrimental or beneficial.³ The direction and impact of such alterations are gene- and region-specific.³ These findings emphasize the complex, context-dependent nature of epigenetic dysregulation in neurodegeneration and highlight potential avenues for targeted therapeutic strategies.